Literature DB >> 9094452

The nature of selection on the major histocompatibility complex.

V Apanius1, D Penn, P R Slev, L R Ruff, W K Potts.   

Abstract

Only natural selection can account for the extreme genetic diversity of genes of the major histocompatibility complex (MHC). Although the structure and function of classic MHC genes is well understood at the molecular and cellular levels, there is controversy about how MHC diversity is selectively maintained. The diversifying selection can be driven by pathogen interactions and inbreeding avoidance mechanisms. Pathogen-driven selection can maintain MHC polymorphism based on heterozygote advantage or frequency-dependent selection due to pathogen evasion of MHC-dependent immune recognition. Empirical evidence demonstrates that specific MHC haplotypes are resistant to certain infectious agents, while susceptible to others. These data are consistent with both heterozygote advantage and frequency-dependent models. Additional research is needed to discriminate between these mechanisms. Infectious agents can precipitate autoimmunity and can potentially contribute to MHC diversity through molecular mimicry and by favoring immunodominance. MHC-dependent abortion and mate choice, based on olfaction, can also maintain MHC diversity and probably functions both to avoid genome-wide inbreeding and produce MHC-heterozygous offspring with increased immune responsiveness. Although this diverse set of hypotheses are often treated as competing alternatives, we believe that they all fit into a coherent, internally consistent thesis. It is likely that at least in some species, all of these mechanisms operate, leading to the extreme diversification found in MHC genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094452     DOI: 10.1615/critrevimmunol.v17.i2.40

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  180 in total

1.  Olfactory fingerprints for major histocompatibility complex-determined body odors.

Authors:  M L Schaefer; D A Young; D Restrepo
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

2.  Major histocompatibility complex variation in the endangered Przewalski's horse.

Authors:  P W Hedrick; K M Parker; E L Miller; P S Miller
Journal:  Genetics       Date:  1999-08       Impact factor: 4.562

3.  The consequences of inbreeding for recognizing competitors.

Authors:  C M Nevison; C J Barnard; R J Beynon; J L Hurst
Journal:  Proc Biol Sci       Date:  2000-04-07       Impact factor: 5.349

Review 4.  Good genes, oxidative stress and condition-dependent sexual signals.

Authors:  T von Schantz; S Bensch; M Grahn; D Hasselquist; H Wittzell
Journal:  Proc Biol Sci       Date:  1999-01-07       Impact factor: 5.349

5.  Heterozygote advantage fails to explain the high degree of polymorphism of the MHC.

Authors:  Rob J De Boer; José A M Borghans; Michiel van Boven; Can Keşmir; Franz J Weissing
Journal:  Immunogenetics       Date:  2004-01-13       Impact factor: 2.846

6.  MHC polymorphism under host-pathogen coevolution.

Authors:  José A M Borghans; Joost B Beltman; Rob J De Boer
Journal:  Immunogenetics       Date:  2004-01-13       Impact factor: 2.846

7.  Do pheromones reveal male immunocompetence?

Authors:  Markus J Rantala; Ilmari Jokinen; Raine Kortet; Anssi Vainikka; Jukka Suhonen
Journal:  Proc Biol Sci       Date:  2002-08-22       Impact factor: 5.349

8.  Gene duplication and gene conversion in class II MHC genes of New Zealand robins (Petroicidae).

Authors:  Hilary C Miller; David M Lambert
Journal:  Immunogenetics       Date:  2004-05-08       Impact factor: 2.846

9.  Frequency-dependent selection with dominance: a window onto the behavior of the mean fitness.

Authors:  Marjorie A Asmussen; Reed A Cartwright; Hamish G Spencer
Journal:  Genetics       Date:  2004-05       Impact factor: 4.562

10.  MHC-disassortative mating preferences reversed by cross-fostering.

Authors:  D Penn; W Potts
Journal:  Proc Biol Sci       Date:  1998-07-22       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.